Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Courses Quicksearch

Search Now!

Courses

From Bench to Bedside: Which Novel Pathways are Most Likely to be Harnessed Therapeutically in the Next 25 Years?

Eric Austin


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Course ID: 2814

CEU Information

Description

The past 30 years have produced tremendous advancements in the field of pulmonary hypertensive vascular disease (PHVD), particularly in pulmonary hypertension. The resultant improvements have bolstered patient quality of life and survival rates. In concert with this progress, there has been a renewed international effort amongst pediatric-focused clinicians to identify the similarities and differences between adult and pediatric patients and to highlight areas unique to the pediatric patient. This class will discuss these similarities and differences, with a particular emphasis on the Panama Classification for Pediatric Pulmonary Hypertensive Vascular Disease, and a focus its relevance to the pediatric patient.

Course Authors

Eric Austin, M.D., MSCI
Vanderbilt University School of Medicine
Nashville, Tenn

Course Reviewer

George J. Vuturo, Ph.D., RPh
CME/CE Director
Chief Compliance Officer
Planning Committee Member
Professional Education Services Group, LLC, Sterling, VA

Content Reviewer

Janice Agazio, Ph.D., CRNP, RN, FAANP, FAAN
Lead Nurse Planner Planning Committee Member Professional Education Services Group, LLC,
Sterling, VA Assistant Dean for Doctoral Programs and Ordinary Professor School
of Nursing the Catholic University of America, Washington, DC

CME Reviewer

Danielle Spencer
CME/CE Project Director
Professional Education Services Group, LLC, Sterling, VA

Intended Audience

This continuing education activity provides continuing education (CE) credits for:

  1. Physicians
  2. Nurses
  3. Pharmacists and Pharmacy Technicians
  4. Respiratory Therapists
  5. Social Workers
  6. Other Related Health Professionals

Learning Objectives

At the conclusion of this activity participants should be able to:

  1. Review why it is important to consider the similarities and differences between pediatric and adult forms of pulmonary hypertensive vascular disease (PHVD).
  2. Understand the consensus approach to the international classification of PHVD, now known as the Panama Classification of Pediatric PHVD.
  3. Review the current approaches to pediatric PH care, including traditional PH-directed therapeutic approaches as well as additional aspects such as procedural planning, preventive care approaches, genetics, and family-centered care issues particularly relevant to pediatrics.

Release Date

January 1, 2016

Expiration Date

December 31, 2017

Estimated Time to Complete This Activity

1 hour

Continuing Education Information

This continuing education activity is provided through a joint Providership Agreement between The Pulmonary Hypertension Association (PHA) and Professional Education Services Group (PESG). This activity will provide continuing education for nurses, pharmacists, respiratory therapists, and social workers. All other health care professionals completing this continuing education activity will be issued Certificate of Attendance which may be submitted to accrediting organizations or licensing boards to meet CE requirements.

Accreditation Statement

Physicians

  • This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of Professional Education Services Group and the Pulmonary Hypertension Association. Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians. This activity has been approved for a maximum of 1.0 hours of AMA PRA Category 1 Credits™. Physicians should only claim credit to the extent of their participation.

Nurses

  • Professional Education Services Group is an accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides a maximum of 1.0 contact hours of nurse CE credit.

Pharmacists and Pharmacy Technicians

  • Professional Education Services Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE UAN 0829-0000-16-184-L04 (Pharmacists) and 0829-0000-16-184-L04 (Pharmacy Technicians). This activity provides 1.0 contact hours (0.10 CEUs) of continuing education credit. There is no cost for this activity. Your record of completion will be reported directly to the CPE Monitor.

Respiratory Therapists

  • The Continuing Respiratory Education (CRCE) system of the American Association for Respiratory Care (AARC) grants approval for 1.0 hours for this course.

Social Workers

  • This program is approved by the National Association of Social Workers for 1.0 Social Work continuing education contact hour

Instructions for Earning Credit

This activity is a self-study program. In order to claim CE credit, participants must:

  1. View the content, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be directed to the CE processing center at http://pha.cds.pesgce.com and claim CE credit.
  2. Complete a post-test and evaluation online. All evaluation questions must be completed in order to receive a CE credit.
  3. Upon successful completion of the post-test and online evaluation form, you can instantly download and/or print your certificate of credit. Your CE records will be stored at http://pha.cds.pesgce.com for later retrieval at your convenience.

CE Inquiries

For all CE related inquiries, please contact Support@PESGCE.com or PHA Online University at (301)-565-3004-x771.

Disclosure Policy

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Professional Educational Services Group (PESG) to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:

Eric Austin, MD, MSCI has no financial or non-financial disclosures, but has indicated the following discussion of unapproved drug or product use: there are no medications approved by the FDA for chronic therapy for pulmonary hypertension in children (short term use of iNO is approved for PPHN).

Disclaimer

The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), the sponsors or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.

Technical Requirements

This course requires an internet browser. For optimum display, please use Mozilla Firefox, Safari or Google Chrome.

Privacy Policy

For information about PHA's privacy policy, visit http://www.PHAssociation.org/PrivacyPolicy.

This activity is made possible through unrestricted educational grants to the PHA Medical Education Fund from Actelion Pharmaceuticals, US; Gilead Sciences, Bayer HealthCare, and United Therapeutics.

©2016 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.